Two Patients with an Identical Novel Mutation in the AAAS Gene and Similar Phenotype of Triple A (Allgrove) Syndrome

Abstract

Background: Triple A syndrome, also known as Allgrove syndrome, is a rare autosomal recessive disorder characterized by three cardinal symptoms: adrenal insufficiency due to ACTH insensitivity, achalasia and alacrima. Various progressive neurological abnormalities and skin changes have been described in association with the syndrome. The disease is caused by mutation in the AAAS gene on chromosome 12q13. AAAS encodes a protein named ALADIN which is part of the nuclear pore complex (NPC). The mislocalization of mutated ALADIN proteins in the cytoplasm and/or the nucleus results in an impaired protein function. Phenotypes of previously reported patients with triple A syndrome varied within and between affected families so that no genotype-phenotype could be established.

Methods: Genetic analysis was performed in two unrelated patients, their parents and one sister. AAAS coding sequences including exon-intron boundaries were amplified and sequenced using an ABI 3100 sequencing machine.

Patients: We present two unrelated Swiss patients with triple A syndrome demonstrating similar phenotypic characteristics. Both showed a progression of the disease presenting with adrenal insufficiency and alacrima in early childhood. At the age between 30–40 years they developed symptomatic achalasia. The pattern and severity of progressive neurological and autonomic dysfunction was comparable. In both patients molecular genetic analysis revealed an identical novel homozygous mutation (c.618delC, p.Ser207fs) in the AAAS gene.

Conclusion: Recent genotype/phenotype studies showed a marked inter- and intrafamiliar variability in triple A syndrome. Here we present a rather tight genotype/phenotype correlation in two unrelated patients carrying the identical novel p.Ser207fs mutation in the AAAS gene.

triple A syndrome - adrenal insufficiency - genetic analysis - genotype - phenotype

References

• 1 Allgrove J, Clayden GS, Grant DB. et al . Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production.  Lancet. 1978;  1 1284-1286
• 2 Cronshaw JM, Krutchinsky AN, Zhang W. et al . Proteomic analysis of the mammalian nuclear pore complex.  J Cell Biol. 2002;  158 915-927
• 3 Cronshaw JM, Matunis MJ. The nuclear pore complex protein ALADIN is mislocalized in triple A syndrome.  Proc Natl Acad Sci U S A. 2003;  100 5823-5827
• 4 Cronshaw JM, Matunis MJ. The nuclear pore complex: disease associations and functional correlations.  Trends Endocrinol Metab. 2004;  15 34-39
• 5 Dumic M, Radica A, Jusic A. et al . Selective ACTH insensitivity associated with autonomic nervous system disorders and sensory polyneuropathy.  Eur J Pediatr. 1987;  146 592-594
• 6 Dumic M, Radica A, Sabol Z. et al . Adrenocorticotropic hormone insensitivity associated with autonomic nervous system disorders.  Eur J Pediatr. 1991;  150 696-699
• 7 Gazarian M, Cowell CT, Bonney M. et al . The “4A” syndrome: adrenocortical insufficiency associated with achalasia, alacrima, autonomic and other neurological abnormalities.  Eur J Pediatr. 1995;  154 18-23
• 8 Grant DB, Barnes ND, Dumic M. et al . Neurological and adrenal dysfunction in the adrenal insufficiency/alacrima/achalasia (3A) syndrome.  Arch Dis Child. 1993;  68 779-782
• 9 Handschug K, Sperling S, Yoon SJ. et al . Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene.  Hum Mol Genet. 2001;  10 283-290
• 10 Houlden H, Smith S, De Carvalho M. et al . Clinical and genetic characterization of families with triple A (Allgrove) syndrome.  Brain. 2002;  125 2681-2690
• 11 Huebner A, Elias LL, Clark AJ. ACTH resistance syndromes.  J Pediatr Endocrinol Metab. 1999;  12 (S 01) 277-293
• 12 Huebner A, Kaindl AM, Knobeloch KP. et al . The triple A syndrome is due to mutations in ALADIN, a novel member of the nuclear pore complex.  Endocr Res. 2004;  30 891-899
• 13 Kimber J, McLean BN, Prevett M. et al . Allgrove or 4 “A” syndrome: an autosomal recessive syndrome causing multisystem neurological disease.  J Neurol Neurosurg Psychiatry. 2003;  74 654-657
• 14 Kinjo S, Takemoto M, Miyako K. et al . Two cases of Allgrove syndrome with mutations in the AAAS gene.  Endocr J. 2004;  51 473-477
• 15 Krumbholz M, Koehler K, Huebner A. Cellular localization of 17 natural mutant variants of ALADIN protein in triple A syndrome – shedding light on an unexpected splice mutation.  Biochem Cell Biol. 2006;  84 243-249
• 16 Milenkovic T, Koehler K, Krumbholz M. et al . Three siblings with triple A syndrome with a novel frameshift mutation in the AAAS gene and a review of 17 independent patients with the frequent p. Ser263Pro mutation.  Eur J Pediatr. 2008;  167 1049-1055
• 17 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells.  Nucleic Acids Res. 1988;  16 1215
• 18 Neer EJ, Schmidt CJ, Nambudripad R. et al . The ancient regulatory protein family of WD-repeat proteins.  Nature (London). 1994;  371 297-300
• 19 Pedreira CC, Zacharin MR. Allgrove syndrome: when a recognisable paediatric disorder occurs in adulthood.  Med J Aust. 2004;  180 74-75
• 20 Prpic I, Huebner A, Persic M. et al . Triple A syndrome: genotype-phenotype assessment.  Clin Genet. 2003;  63 415-417
• 21 Sandrini F, Farmakidis C, Kirschner LS. et al . Spectrum of mutations of the AAAS gene in Allgrove syndrome: lack of mutations in six kindreds with isolated resistance to corticotropin.  J Clin Endocrinol Metab. 2001;  86 5433-5437
• 22 Schuelke M. An economic method for the fluorescent labeling of PCR fragments.  Nat Biotechnol.. 2000;  18 233-234
• 23 Smith TF, Gaitatzes C, Saxena K. et al . The WD repeat: a common architecture for diverse functions.  Trends Biochem. Sci.. 1999;  24 181-185
• 24 Tullio-Pelet A, Salomon R, Hadj-Rabia S. et al . Mutant WD-repeat protein in triple-A syndrome.  Nat Genet. 2000;  26 332-335

Correspondence